{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:08:24Z","timestamp":1795118904582,"version":"4.10.3"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012774","name":"Innovation Fund","doi-asserted-by":"publisher","award":["9084-00020B"],"award-info":[{"award-number":["9084-00020B"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007405","name":"Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R278-2018-804"],"award-info":[{"award-number":["R278-2018-804"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.atherosclerosis.2024.118614","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T09:02:30Z","timestamp":1727082150000},"page":"118614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Lipids, lipoproteins, and apolipoproteins: Associations with cognition and dementia"],"prefix":"10.1016","volume":"398","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0994-1993","authenticated-orcid":false,"given":"Ida","family":"Juul Rasmussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Frikke-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-021-10429-0","article-title":"Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017","volume":"21","author":"Amini","year":"2021","journal-title":"BMC Publ. Health"},{"key":"10.1016\/j.atherosclerosis.2024.118614_bib2","series-title":"Stevens JH and DMF. WHO Methods and Data Sources for Country-Level Causes of Death","first-page":"1","author":"Cao","year":"2020"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2024.118614_bib3","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"The Lancet Commissions Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cger.2022.07.006","article-title":"Vascular and nonvascular mechanisms of cognitive impairment and dementia","volume":"39","author":"Kara","year":"2023","journal-title":"Clin. Geriatr. Med."},{"issue":"10452","key":"10.1016\/j.atherosclerosis.2024.118614_bib5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.118614_bib6","first-page":"1","article-title":"Plasma lipids as biomarkers for Alzheimer's disease: a systematic review","volume":"4","author":"Agarwal","year":"2020","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10557-020-07045-2","article-title":"Impact of lowering low-density lipoprotein cholesterol with contemporary lipid-lowering medicines on cognitive function: a systematic review and meta-analysis","volume":"35","author":"Ying","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.118614_bib8","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.118614_bib9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer's disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.118614_bib10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","article-title":"Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk","volume":"51","author":"Jansen","year":"2019","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.118614_bib11","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.118614_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.atherosclerosis.2019.12.005","article-title":"Quantifying atherogenic lipoproteins for lipid-lowering strategies : consensus-based recommendations from EAS and EFLM","volume":"294","author":"Nordestgaard","year":"2020","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2019","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S2213-8587(19)30264-5","article-title":"Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement","volume":"8","author":"Hegele","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.118614_bib15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MOL.0000000000000291","article-title":"Relation between plasma and brain lipids","volume":"27","author":"Wellington","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"issue":"22","key":"10.1016\/j.atherosclerosis.2024.118614_bib16","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1093\/eurheartj\/ehy068","article-title":"Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease","volume":"39","author":"Qayyum","year":"2018","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib17","article-title":"HDL cholesterol concentrations and risk of atherosclerotic cardiovascular disease \u2013 insights from randomized clinical trials and human genetics","volume":"1867","author":"Kjeldsen","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.118614_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000079200","article-title":"Relation of apolipoprotein(a) size to Alzheimer's disease and vascular dementia","volume":"18","author":"Emanuele","year":"2004","journal-title":"Dement. Geriatr. Cogn. Disord"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib19","first-page":"76","article-title":"Lipoprotein (a): structure, pathophysiology and clinical implications","volume":"103","author":"Maranh\u00e3o","year":"2014","journal-title":"Arq. Bras. Cardiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/MOL.0000000000000723","article-title":"Impact of metabolic dysfunction on cognition in humans","volume":"32","author":"Juul","year":"2021","journal-title":"Curr. Opin. Lipidol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.118614_bib21","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to \u03b2-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.atherosclerosis.2024.118614_bib22","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2024.118614_bib23","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of Apolipoprotein E allele \u03b54 with late-onset familial and sporadic Alzheimer's disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.118614_bib24","first-page":"1034","article-title":"Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage","volume":"48","author":"Pericak-Vance","year":"1991","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.118614_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain\u2014implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.118614_bib26","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood-brain barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.118614_bib27","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.atherosclerosis.2024.118614_bib28","volume":"vol. 2","year":"2010"},{"key":"10.1016\/j.atherosclerosis.2024.118614_bib29","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"issue":"28","key":"10.1016\/j.atherosclerosis.2024.118614_bib30","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/eurheartj\/ehad293","article-title":"Modifiable cardiovascular risk factors and genetics for targeted prevention of dementia","volume":"44","author":"Juul Rasmussen","year":"2023","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.118614_bib31","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of Health and human services task force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.118614_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer's Dementia"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.118614_bib33","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/WAD.0000000000000034","article-title":"Diagnostic criteria for vascular cognitive disorders","volume":"28","author":"Sachdev","year":"2014","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib34","article-title":"The relationship between midlife dyslipidemia and lifetime incidence of dementia: a systematic review and meta-analysis of cohort studies","volume":"15","author":"Wee","year":"2023","journal-title":"Alzheimer's Dementia"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.118614_bib35","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/acn3.51516","article-title":"Lipid levels and the risk of dementia: a dose\u2013response meta-analysis of prospective cohort studies","volume":"9","author":"Zhu","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2024.118614_bib36","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1212\/WNL.0b013e3181feb2bf","article-title":"The 32-year relationship between cholesterol and dementia from midlife to late life","volume":"75","author":"Mielke","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, apolipoprotein E \u03b54 allele, and Alzheimer's disease","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"issue":"June","key":"10.1016\/j.atherosclerosis.2024.118614_bib38","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.118614_bib39","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1016\/S2666-7568(21)00150-1","article-title":"Blood cholesterol and risk of dementia in more than 1\u00b78 million people over two decades: a retrospective cohort study","volume":"2","author":"Iwagami","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.atherosclerosis.2024.118614_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101695","article-title":"Serum lipid traits and the risk of dementia: a cohort study of 254,575 women and 214,891 men in the UK Biobank","volume":"54","author":"Gong","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.118614_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-137-3-200208060-00006","article-title":"Apolipoprotein E \u03b54 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease","volume":"137","author":"Kivipelto","year":"2002","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.118614_bib42","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1212\/01.wnl.0000256368.57375.b7","article-title":"Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study","volume":"68","author":"Solomon","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.atherosclerosis.2024.118614_bib43","first-page":"1","article-title":"Associations of dietary cholesterol and fat, blood lipids, and risk for dementia in older women vary by APOE genotype","author":"Dunk","year":"2023","journal-title":"Alzheimer's Dementia"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.118614_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1002265","article-title":"Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: a longitudinal, population-based prospective cohort study","volume":"14","author":"Schilling","year":"2017","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43856-022-00234-0","article-title":"Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes","volume":"3","author":"Schmidt","year":"2023","journal-title":"Commun. Med."},{"key":"10.1016\/j.atherosclerosis.2024.118614_bib46","article-title":"Modifiable pathways in Alzheimer's disease: mendelian randomisation analysis","volume":"359","author":"Larsson","year":"2017","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.118614_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001841","article-title":"Associations between potentially modifiable risk factors and alzheimer disease: a mendelian randomization study","volume":"12","author":"\u00d8stergaard","year":"2015","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12920-023-01692-8","article-title":"Causal relationships between blood lipids and major psychiatric disorders: univariable and multivariable mendelian randomization analysis","volume":"16","author":"Li","year":"2023","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.atherosclerosis.2024.118614_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.660212","article-title":"Mendelian randomization of dyslipidemia on cognitive impairment among older Americans","volume":"12","author":"Fu","year":"2021","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.118614_bib50","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/EDE.0000000000001072","article-title":"Survival bias in mendelian randomization studies: a threat to causal inference","volume":"30","author":"Smit","year":"2019","journal-title":"Epidemiology"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.118614_bib51","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1212\/01.WNL.0000158274.31318.3C","article-title":"Impact of plasma lipids and time on memory performance in healthy elderly without dementia","volume":"64","author":"Reitz","year":"2005","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.118614_bib52","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/jnnp-2021-328164","article-title":"LDL cholesterol is associated with higher AD neuropathology burden independent of APOE","volume":"93","author":"Wingo","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.118614_bib54","first-page":"1","article-title":"Genetic associations between modifiable risk factors and alzheimer disease","volume":"6","author":"Luo","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/nu15010069","article-title":"Associations of lipids and lipid-lowering drugs with risk of vascular dementia: a mendelian randomization study","volume":"15","author":"Zhang","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib56","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/clinchem\/hvaa269","article-title":"Triglycerides as a shared risk factor between dementia and atherosclerotic cardiovascular disease: a study of 125 727 individuals","volume":"67","author":"Nordestgaard","year":"2021","journal-title":"Clin. Chem."},{"issue":"22","key":"10.1016\/j.atherosclerosis.2024.118614_bib57","doi-asserted-by":"crossref","first-page":"e2288","DOI":"10.1212\/WNL.0000000000207923","article-title":"Association between triglycerides and risk of dementia in community-dwelling older adults: a prospective cohort study","volume":"101","author":"Zhou","year":"2023","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.118614_bib58","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1037\/neu0000335","article-title":"Triglycerides are negatively correlated with cognitive function in nondemented aging adults","volume":"31","author":"Parthasarathy","year":"2017","journal-title":"Neuropsychology"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.118614_bib53","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/ene.15219","article-title":"Association of major blood lipids with post-stroke dementia: a community-based cohort study","volume":"29","author":"Yang","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.118614_bib59","doi-asserted-by":"crossref","first-page":"E1127","DOI":"10.1212\/WNL.0000000000207595","article-title":"Association between fluctuations in blood lipid levels over time with incident alzheimer disease and alzheimer disease-related dementias","volume":"101","author":"Moser","year":"2023","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib60","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41398-018-0336-y","article-title":"The association between midlife serum high-density lipoprotein and mild cognitive impairment and dementia after 19 years of follow-up","volume":"9","author":"Svensson","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.118614_bib61","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/cvr\/cvab164","article-title":"Plasma high-density lipoprotein cholesterol and risk of dementia: observational and genetic studies","volume":"118","author":"Kjeldsen","year":"2022","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.118614_bib62","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ana.24326","article-title":"Plasma levels of Apolipoprotein E and risk of dementia in the general population","volume":"77","author":"Rasmussen","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.atherosclerosis.2024.118614_bib63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neulet.2016.02.018","article-title":"Serum Apolipoprotein E is associated with long-term risk of Alzheimer's disease: the Rotterdam Study","volume":"617","author":"Wolters","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib64","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jalz.2017.05.006","article-title":"Plasma apolipoprotein E levels and risk of dementia: a Mendelian randomization study of 106,562 individuals","volume":"14","author":"Rasmussen","year":"2018","journal-title":"Alzheimer's Dementia"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.118614_bib65","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/alz.12165","article-title":"APOE and dementia \u2013 resequencing and genotyping in 105,597 individuals","volume":"16","author":"Rasmussen","year":"2020","journal-title":"Alzheimer's Dementia"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.118614_bib66","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/mp.2011.52","article-title":"APOE and Alzheimer disease: a major gene with semi-dominant inheritance","volume":"16","author":"Genin","year":"2011","journal-title":"Mol. Psychiatr."},{"issue":"35","key":"10.1016\/j.atherosclerosis.2024.118614_bib67","doi-asserted-by":"crossref","first-page":"E1033","DOI":"10.1503\/cmaj.180066","article-title":"Absolute 10-year risk of dementia by age, sex and APOE genotype: a population-based cohort study","volume":"190","author":"Rasmussen","year":"2018","journal-title":"Can. Med. Assoc. J."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib68","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41398-020-0822-x","article-title":"Causal association of circulating cholesterol levels with dementia: a mendelian randomization meta-analysis","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2024.118614_bib69","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib70","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41467-019-14279-8","article-title":"Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study","volume":"11","author":"Reiman","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.118614_bib71","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/STROKEAHA.119.026927","article-title":"APOE-\u03f54 genotype and dementia before and after transient ischemic attack and stroke: population-based cohort study","volume":"51","author":"Pendlebury","year":"2020","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.118614_bib72","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S1474-4422(18)30053-X","article-title":"The effect of APOE and other common genetic variants on the onset of Alzheimer's disease dementia: a community-based cohort study","volume":"17","author":"van der Lee","year":"2018","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.118614_bib73","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/1206","article-title":"APOE genotype predicts when - not whether - one is predisposed to develop Alzheimer disease","volume":"19","author":"Meyer","year":"1998","journal-title":"Nat. Genet."},{"issue":"41","key":"10.1016\/j.atherosclerosis.2024.118614_bib74","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1093\/eurheartj\/ehaa695","article-title":"Impact of cardiovascular risk factors and genetics on 10-year absolute risk of dementia: risk charts for targeted prevention","volume":"41","author":"Juul","year":"2020","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.118614_bib75","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-0039-1687907","article-title":"Vascular disease and dementia: lipoprotein (a) as a neglected link","volume":"45","author":"Lippi","year":"2019","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.atherosclerosis.2024.118614_bib76","first-page":"743","article-title":"Lp(a) lipoprotein in cerebrovascular disease and dementia","volume":"41","author":"Urakami","year":"1988","journal-title":"Jpn. J. Psychiatry Neurol."},{"key":"10.1016\/j.atherosclerosis.2024.118614_bib77","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000017226","article-title":"Lipoprotein(a) phenotypes in patients with vascular dementia","volume":"11","author":"Urakami","year":"2000","journal-title":"Dement. Geriatr. Cogn. Disord"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.118614_bib78","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.metabol.2003.11.020","article-title":"Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia","volume":"53","author":"Watanabe","year":"2004","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.118614_bib79","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5551\/jat.E608","article-title":"Increased plasma urotensin-II and carotid atherosclerosis are associated with vascular dementia","volume":"16","author":"Ban","year":"2009","journal-title":"J. Atherosclerosis Thromb."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.118614_bib80","first-page":"57","article-title":"Serum homocysteine, dehydroepiandrosterone sulphate and lipoprotein (a) in Alzheimer's disease and vascular dementia","volume":"4","author":"Ray","year":"2013","journal-title":"Aging Dis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.118614_bib81","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/jnnp.72.6.732","article-title":"Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease","volume":"72","author":"Solfrizzi","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib82","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0404.1999.tb00724.x","article-title":"Increased apolipoprotein B serum concentration in Alzheimer's disease","volume":"100","author":"Caramelli","year":"1999","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib83","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2003.12.043","article-title":"Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease","volume":"357","author":"Emanuele","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.atherosclerosis.2024.118614_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2318-1-5","article-title":"Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease","volume":"1","author":"Zuliani","year":"2001","journal-title":"BMC Geriatr."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.118614_bib85","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-132-7-200004040-00004","article-title":"Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease","volume":"132","author":"Mooser","year":"2000","journal-title":"Ann. Intern. Med."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.118614_bib86","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s10654-016-0184-0","article-title":"Is lipoprotein (a) protective of dementia?","volume":"31","author":"Kunutsor","year":"2016","journal-title":"Eur. J. Epidemiol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.118614_bib87","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1161\/01.STR.32.7.1678","article-title":"Lipoprotein(a) and cognitive performances in an elderly white population: cross-sectional and follow-up data","volume":"32","author":"Sarti","year":"2001","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.118614_bib88","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1161\/STROKEAHA.119.026872","article-title":"Causal effect of Lp(a) [lipoprotein(a)] level on ischemic stroke and alzheimer disease a mendelian randomization study","volume":"50","author":"Pan","year":"2019","journal-title":"Stroke"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2024.118614_bib89","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/CIRCULATIONAHA.120.045826","article-title":"Lipoprotein(a) in alzheimer, atherosclerotic, cerebrovascular, thrombotic, and valvular disease: mendelian randomization investigation","volume":"141","author":"Larsson","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.118614_bib90","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/eurjpc\/zwab208","article-title":"Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies","volume":"29","author":"Olmastroni","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"s1","key":"10.1016\/j.atherosclerosis.2024.118614_bib91","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.3233\/JAD-190181","article-title":"A systematic review of meta-analyses that evaluate risk factors for dementia to evaluate the quantity, quality, and global representativeness of evidence","volume":"70","author":"Anstey","year":"2019","journal-title":"J. Alzheim. Dis."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib92","first-page":"CD003160","article-title":"Statins for the prevention of dementia","volume":"2016","author":"McGuinness","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.118614_bib93","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.neurobiolaging.2007.09.012","article-title":"Serum total cholesterol, statins and cognition in non-demented elderly","volume":"30","author":"Solomon","year":"2009","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.2008.150433","article-title":"Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study","volume":"80","author":"Haag","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.118614_bib95","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/archneur.62.7.1047","article-title":"Statin use and the risk of incident dementia: the Cardiovascular Health Study","volume":"62","author":"Rea","year":"2005","journal-title":"Arch. Neurol."},{"issue":"1\u20133","key":"10.1016\/j.atherosclerosis.2024.118614_bib96","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000295659","article-title":"Lipid-lowering treatment is related to decreased risk of dementia: a population-based study (FINRISK)","volume":"7","author":"Solomon","year":"2010","journal-title":"Neurodegener. Dis."},{"issue":"21","key":"10.1016\/j.atherosclerosis.2024.118614_bib97","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.jacc.2019.09.041","article-title":"Effects of statins on memory, cognition, and brain volume in the elderly","volume":"74","author":"Samaras","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.118614_bib98","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.11.002","article-title":"Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study","volume":"21","author":"Bettermann","year":"2012","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"5519","key":"10.1016\/j.atherosclerosis.2024.118614_bib99","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase published","volume":"292","author":"Istvan","year":"1979","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.atherosclerosis.2024.118614_bib100","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1212\/01.wnl.0000288181.00826.63","article-title":"Statins, incident Alzheimer disease, change in cognitive function, and neuropathology","volume":"70","author":"Arvanitakis","year":"2008","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.118614_bib101","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Gorelick","year":"2011","journal-title":"Stroke"},{"issue":"46","key":"10.1016\/j.atherosclerosis.2024.118614_bib102","doi-asserted-by":"crossref","first-page":"16458","DOI":"10.1523\/JNEUROSCI.3987-12.2012","article-title":"LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-\u03b2","volume":"32","author":"Kanekiyo","year":"2012","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.118614_bib103","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","article-title":"Apolipoprotein E in Alzheimer's disease and other neurological disorders","volume":"10","author":"Verghese","year":"2011","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib104","first-page":"11","article-title":"Human apolipoprotein E isoprotein subclasses are genetically determined","volume":"33","author":"Zannis","year":"1981","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.118614_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106740","article-title":"Plant sterols and cholesterol metabolism are associated with five-year cognitive decline in the elderly population","volume":"26","author":"Clark","year":"2023","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib106","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1212\/WNL.0000000000004749","article-title":"Increased midlife triglycerides predict brain \u03b2-amyloid and tau pathology 20 years later","volume":"90","author":"N\u00e4gga","year":"2018","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.118614_bib107","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/brainsci10060386","article-title":"Cholesterol and Alzheimer's disease risk: a meta-meta-analysis","volume":"10","author":"S\u00e1iz-Vazquez","year":"2020","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib108","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s13311-021-01170-y","article-title":"Vascular cognitive impairment (VCI)","volume":"19","author":"Rundek","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.atherosclerosis.2024.118614_bib109","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2016.10.037","article-title":"Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: a review","volume":"255","author":"Rasmussen","year":"2016","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.118614_bib110","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jama.298.11.1300","article-title":"Association of apolipoprotein e genotypes with lipid levels and coronary risk","volume":"298","author":"Bennet","year":"2007","journal-title":"JAMA"},{"issue":"March","key":"10.1016\/j.atherosclerosis.2024.118614_bib111","first-page":"1","article-title":"Cholesterol, atherosclerosis, and APOE in vascular contributions to cognitive impairment and dementia (VCID): potential mechanisms and therapy","volume":"13","author":"Duong","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118614_bib112","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.118614_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbm4.10675","article-title":"A guide for understanding and designing mendelian randomization studies in the musculoskeletal field","volume":"6","author":"Hartley","year":"2022","journal-title":"JBMR Plus"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024011869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024011869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:37:52Z","timestamp":1777441072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024011869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":113,"alternative-id":["S0021915024011869"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118614","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipids, lipoproteins, and apolipoproteins: Associations with cognition and dementia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"118614"}}